Keywords: Lundbeck, Onfi, Clobazam, Lennox-Gastaut syndrome, USA, FDA

Lundbeck gets US FDA backing for Onfi to treat severe type of seizures

Article | 25 October 2011

Print This

Danish drugmaker Lundbeck (LUND: DC) yesterday received approval from the US Food and Drug Administration for Onfi (clobazam) as adjunctive ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in